[CIS PIDD] [cis-pidd] Renal transplantation in CVID

Mon Jun 8 17:13:51 EDT 2015

Jack- Do you have experience with any particular drug in nodular regenerative hyperplasia. In my experience also, a terrible disease.

Mel Berger
________________________________________
From: Routes, John [jroutes at mcw.edu]
Sent: Monday, June 08, 2015 4:05 PM
To: CIS-PIDD
Subject: Re: [cis-pidd] Renal transplantation in CVID

Stan
Are you sure the liver pathology wasn’t nodular regenerative hyperplasia—certainly has the clinical features of this? If so, then immunosuppressives would be needed as this is increasingly recognized as a potentially fatal complication of CVID
Jack

John M. Routes, MD
Chief, Section of Allergy and Clinical Immunology
Professor of Pediatrics, Medicine, Microbiology and Molecular Genetics
Department of Pediatrics
Children's Hospital of Wisconsin
Medical College of Wisconsin
9000 W. Wisconsin Ave.
Milwaukee, WI  53226-4874
Phone: Office 414-266-6840
Fax: 414-955-6487 (Clinical)
Fax: 414-955-6323 (Laboratory)
Email: jroutes at mcw.edu<mailto:jroutes at mcw.edu>

From: Bodo Grimbacher <bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>>
Reply-To: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Date: Monday, June 8, 2015 at 2:59 PM
To: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Subject: Re: [cis-pidd] Renal transplantation in CVID

Dear Stan,
We have many patients with CVID and autoimmune features on immunosupressive treatment.
If you take care of good trough levels and give antibiotics early and long enough, the bronchiectatic lung disease may not progress at all.
Immunosupression may actually help the granulomatous complications seen in your patient.
So it is a clear option for your patient.
We do prefer steroids and MMF over the other immunosupressants though…
Best, Bodo
****************************************
Univ.-Prof. Dr. med. B. Grimbacher

Scientific-Director
CCI-Center for Chronic Immunodeficiency
UNIVERSITÄTSKLINIKUM FREIBURG
Tel.: 0761 270-77731  Fax: -77744
Engesserstraße 4, 79108 Freiburg
bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>
www.uniklinik-freiburg.de/cci

Von: Stan Ress <stan.ress at uct.ac.za<mailto:stan.ress at uct.ac.za>>
Antworten an: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Datum: Monday 8 June 2015 21:42
An: CIS-PIDD <cis-pidd at lyris.dundee.net<mailto:cis-pidd at lyris.dundee.net>>
Betreff: [cis-pidd] Renal transplantation in CVID

Dear Colleagues,

I would be grateful for advice regarding further management in a complicated case of CVID.

A 35 year-old lady was diagnosed with CVID in 2008 and commenced on IVIG. She has had a complicated course. In 2010  a chest CT scan showed bilateral bronchiectasis as a result of recurrent RTI’s. She then developed hepatomegaly and progressive splenomegaly. Bone marrow trephines done at another centre in 2008 & 2010 showed normal T-and B-cell gene rearrangements, but she developed severe bicytopenia due to hypersplenism, and eventually required splenectomy in April 2014 when splenic size was 24 cm, platelet count < 80, WCC  < 1.5. US and MRI of liver indicated increased porta-venous shunting of blood with portal hypertension, liver biopsy reported features compatible with focal nodular hyperplasia (FNH) with T-cell infiltration but no B-cells present. Liver enzymes then progressively increased post-splenectomy (alkaline phosphatase & gamma GT especially), this has improved on low dose prednisone. However, her renal function had also deteriorated and simultaneous renal biopsy (at the time of splenectomy)  was reported as showing interstitial nephritis.

She is managed on SC Immunoglobulin replacement, her current renal function has been stable with serum urea of 22 mmol/L  (2.8-7.2), creatinine of 371 umol/L (estimated GFR of 12 ml/min). Her nephrologist is exploring the possibility of a live related renal transplant and asks about the experience in this regard. While the QOL on haemodialysis would be less good than following a renal transplant, my concern is for the effect of immune suppression on an already immunocompromised patient who also has bronchiectasis.

We would appreciate any advice and would also be grateful to hear of any other experience with regard to transplantation in CVID patients.

Many thanks.

Stan
-------------------
Stanley Ress
Emeritus Associate Professor of Medicine, UCT
Specialist physician & Clinical Immunologist
UCT Private Academic hospital,
Anzio Road, Observatory,
Cape Town, 7925
South Africa
TEL:INTERN<tel:INTERN>. + 2721-4421966 or 4421816
FAX:   "    + 2721-(0)865173095
Cell: 0833115482
email: stan.ress at uct.ac.za<mailto:stan.ress at uct.ac.za>

________________________________
UNIVERSITY OF CAPE TOWN

This e-mail is subject to the UCT ICT policies and e-mail disclaimer published on our website at http://www.uct.ac.za/about/policies/emaildisclaimer/ or obtainable from +27 21 650 9111. This e-mail is intended only for the person(s) to whom it is addressed. If the e-mail has reached you in error, please notify the author. If you are not the intended recipient of the e-mail you may not use, disclose, copy, redirect or print the content. If this e-mail is not related to the business of UCT it is sent by the sender in the sender's individual capacity.

---

You are currently subscribed to cis-pidd as: bodo.grimbacher at uniklinik-freiburg.de<mailto:bodo.grimbacher at uniklinik-freiburg.de>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a&n=T&l=cis-pidd&o=2892887

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2892887-96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a at lyris.dundee.net<mailto:leave-2892887-96396431.4f2a33ac30bfa58d3a76b5fb5b03d33a at lyris.dundee.net>

---

You are currently subscribed to cis-pidd as: jroutes at mcw.edu<mailto:jroutes at mcw.edu>.

To unsubscribe click here: http://cts.dundee.net/u?id=96396698.0f5699ec627ea78458de58d3499414e5&n=T&l=cis-pidd&o=2892935

(It may be necessary to cut and paste the above URL if the line is broken)

or send a blank email to leave-2892935-96396698.0f5699ec627ea78458de58d3499414e5 at lyris.dundee.net<mailto:leave-2892935-96396698.0f5699ec627ea78458de58d3499414e5 at lyris.dundee.net>

---
You are currently subscribed to cis-pidd as: mel.berger at cslbehring.com.
To unsubscribe click here: http://cts.dundee.net/u?id=99073787.58ab5b023d7523deefb05f1dfd950d72&n=T&l=cis-pidd&o=2892953
or send a blank email to leave-2892953-99073787.58ab5b023d7523deefb05f1dfd950d72 at lyris.dundee.net

This email, including any attachments, is confidential and contains proprietary content and may be legally privileged. This transmission is intended only for the designated recipient(s), and any duplication or distribution, in any form or part, without the written consent of the sender is strictly prohibited. These confidentiality protections apply even if you received this transmission in error, in which case you should delete the message, disregard its contents and notify the sender of the mistake. CSL Behring

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=2893156
or send a blank email to leave-2893156-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net